Nothing Special   »   [go: up one dir, main page]

BR0215174A - Derivados de 3-heteroaril-3,5-diidro-4-oxo-4h-piridazino[4,5-b]indol 1-carboxamida, sua preparação e sua aplicação em terapêutica - Google Patents

Derivados de 3-heteroaril-3,5-diidro-4-oxo-4h-piridazino[4,5-b]indol 1-carboxamida, sua preparação e sua aplicação em terapêutica

Info

Publication number
BR0215174A
BR0215174A BR0215174-0A BR0215174A BR0215174A BR 0215174 A BR0215174 A BR 0215174A BR 0215174 A BR0215174 A BR 0215174A BR 0215174 A BR0215174 A BR 0215174A
Authority
BR
Brazil
Prior art keywords
preparation
heteroaryl
therapeutic application
carboxamide derivatives
group
Prior art date
Application number
BR0215174-0A
Other languages
English (en)
Inventor
Philippe Burnier
Jacques Froissant
Benoit Marabout
Frank Marguet
Frederic Puech
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR0215174A publication Critical patent/BR0215174A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DE 3-HETEROARIL-3,5-DIIDRO-4OXO-4H-PIRIDAZINO[4,5-b]INDOL- 1-CARBOXAMIDA, SUA PREPARAçãO E SUA APLICAçãO EM TERAPêUTICA". A presente invenção refere-se aos compostos de fórmula geral na qual X representa um átomo de hidrogênio ou de halogênio; R, representa um átomo de hidrogênio ou um grupo (C~ 1~-C~ 4~)alquila; R~ 2~ e R~ 3~ representam cada um deles, independentemente um do outro, um átomo de hidrogênio ou um grupo (C~ 1~-C~ 4~)alquila, ou então R~ 2~ e R~ 3~ formam, com o átomo de nitrogênio que os porta, um grupo pirrolidinila, piperidinila, morfolinila ou 4-alquilpiperazinila; e Het representa um grupo heteroaromático de tipo piridinila, 1-oxidopiridinila, quinolinila, isoquinolinila, pirimidinila, pirazinila, piridazinila, o grupo heteroaromático podendo portar um ou vários átomos de halogênio e/ou um ou vários grupos (C~ 1~-C~ 4~)alquila, (C~ 1~-C~ 4~)alcoxila, no estado de bases, de sais de adição ácidos, de solvatos ou de hidratos, as composições farmacêuticas que os contêm, processos para a preparação dos mesmos e dos intermediários de síntese.
BR0215174-0A 2001-12-21 2002-11-20 Derivados de 3-heteroaril-3,5-diidro-4-oxo-4h-piridazino[4,5-b]indol 1-carboxamida, sua preparação e sua aplicação em terapêutica BR0215174A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116701A FR2833953B1 (fr) 2001-12-21 2001-12-21 DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR0205338 2002-11-20

Publications (1)

Publication Number Publication Date
BR0215174A true BR0215174A (pt) 2004-11-30

Family

ID=8870861

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215174-0A BR0215174A (pt) 2001-12-21 2002-11-20 Derivados de 3-heteroaril-3,5-diidro-4-oxo-4h-piridazino[4,5-b]indol 1-carboxamida, sua preparação e sua aplicação em terapêutica

Country Status (33)

Country Link
US (4) US7109194B2 (pt)
EP (1) EP1458721B1 (pt)
JP (1) JP5087204B2 (pt)
KR (1) KR100936565B1 (pt)
CN (1) CN100376579C (pt)
AR (1) AR038024A1 (pt)
AT (1) ATE346069T1 (pt)
AU (1) AU2002361325B2 (pt)
BR (1) BR0215174A (pt)
CA (1) CA2465750C (pt)
CY (1) CY1106029T1 (pt)
DE (1) DE60216321T2 (pt)
DK (1) DK1458721T3 (pt)
EA (1) EA006251B1 (pt)
ES (1) ES2276978T3 (pt)
FR (1) FR2833953B1 (pt)
HK (1) HK1065792A1 (pt)
HR (1) HRP20040549B1 (pt)
HU (1) HU229419B1 (pt)
IL (2) IL161859A0 (pt)
IS (1) IS2380B (pt)
ME (2) ME00117B (pt)
MX (1) MXPA04006144A (pt)
NO (1) NO328587B1 (pt)
NZ (1) NZ532996A (pt)
PL (1) PL371201A1 (pt)
PT (1) PT1458721E (pt)
RS (1) RS51103B (pt)
SI (1) SI1458721T1 (pt)
TW (1) TWI275391B (pt)
UA (1) UA77984C2 (pt)
WO (1) WO2003055884A1 (pt)
ZA (1) ZA200404245B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
US7732447B2 (en) * 2006-06-22 2010-06-08 Cephalon, Inc. Fused [d]pyridazin-7-ones
CN1995041B (zh) * 2006-12-18 2012-06-27 沈阳药科大学 哒嗪并吲哚类衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2811990A1 (fr) 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Also Published As

Publication number Publication date
CA2465750C (en) 2011-05-31
US20080249098A1 (en) 2008-10-09
DK1458721T3 (da) 2007-03-26
EA006251B1 (ru) 2005-10-27
DE60216321T2 (de) 2007-06-21
US7109194B2 (en) 2006-09-19
EA200400560A1 (ru) 2004-12-30
ATE346069T1 (de) 2006-12-15
HRP20040549B1 (hr) 2012-10-31
CY1106029T1 (el) 2011-04-06
ES2276978T3 (es) 2007-07-01
KR100936565B1 (ko) 2010-01-13
IL161859A0 (en) 2005-11-20
EP1458721A1 (fr) 2004-09-22
PL371201A1 (en) 2005-06-13
FR2833953A1 (fr) 2003-06-27
PT1458721E (pt) 2007-02-28
US20050096321A1 (en) 2005-05-05
US7569567B2 (en) 2009-08-04
IS7259A (is) 2004-05-10
CN1604898A (zh) 2005-04-06
ZA200404245B (en) 2005-08-31
TW200301120A (en) 2003-07-01
DE60216321D1 (de) 2007-01-04
JP5087204B2 (ja) 2012-12-05
AU2002361325A1 (en) 2003-07-15
AU2002361325B2 (en) 2008-10-02
EP1458721B1 (fr) 2006-11-22
ME00117B (me) 2010-06-10
UA77984C2 (en) 2007-02-15
NO328587B1 (no) 2010-03-22
CN100376579C (zh) 2008-03-26
FR2833953B1 (fr) 2004-12-03
NO20042536L (no) 2004-09-21
NZ532996A (en) 2006-11-30
KR20040068958A (ko) 2004-08-02
MEP22408A (en) 2010-06-10
HU229419B1 (en) 2013-12-30
US20060241116A1 (en) 2006-10-26
MXPA04006144A (es) 2004-11-01
JP2005513158A (ja) 2005-05-12
RS51103B (sr) 2010-10-31
US7402682B2 (en) 2008-07-22
CA2465750A1 (en) 2003-07-10
US20090275576A1 (en) 2009-11-05
IL161859A (en) 2009-11-18
HRP20040549A2 (en) 2004-10-31
AR038024A1 (es) 2004-12-22
WO2003055884A1 (fr) 2003-07-10
SI1458721T1 (sl) 2007-04-30
HUP0402578A2 (hu) 2005-03-29
HK1065792A1 (en) 2005-03-04
TWI275391B (en) 2007-03-11
HUP0402578A3 (en) 2009-01-28
IS2380B (is) 2008-07-15
RS50304A (en) 2006-12-15

Similar Documents

Publication Publication Date Title
HRP20020712B1 (hr) Farmaceutske strukture koje sadrže derivate azetidina, novi derivati azetidina i njihovo pripremanje
BR0308696A (pt) Derivados de quinolina e seu emprego como ligante de 5-ht6
HUP0303146A2 (hu) Protein kináz gátló hatású 3-(4-amido-pirrol-2-il-metilidén)-2-indolinon származékok és ezeket tartalmazó gyógyszerkészítmények
BRPI0519794A2 (pt) derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
TW200502225A (en) Heterocyclic compounds useful as nurr-1 activators
DK1254134T3 (da) Derivater af 1,3-dihydro-2H-indol-2-on og deres anvendelse som ligander for argininvasopressinreceptorerne V1B eller V1B og V1A
CO5550439A2 (es) Compuestos derivados de arilsulfonil-piperazina que tienen afinidad al receptor 5-ht6 y composiciones farmaceuticas que los contienen
BR0115520A (pt) Derivados de 4-(bifenilcarbonilamino) piperidina como inibidores da mtp
AR041689A1 (es) Derivados de piridoindolona substituidos en 3- por un fenilo su preparacion y su aplicacion en terapeutica
BR0215174A (pt) Derivados de 3-heteroaril-3,5-diidro-4-oxo-4h-piridazino[4,5-b]indol 1-carboxamida, sua preparação e sua aplicação em terapêutica
BR0115480A (pt) Derivados de pirimidina
BRPI0414460A (pt) compostos derivados de carboxamida do tipo de amida, composição farmacêutica e respectivo uso
HUP0203603A2 (hu) Új IL-8 receptor antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények
BR0309018A (pt) Derivados de 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino[4,5-b]ind ol-1-acetamida, sua preparação e sua aplicação em terapêutica
BR9916188A (pt) Derivados de cromano
BR0213176A (pt) Derivados microbiocidas de n-fenil-n-[4-(4-piridil)-2-pirimidin-2-il]amina
AR020773A1 (es) Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto
BR0306707A (pt) Derivados de 5-(piridin-3-il)-1-azabiciclo[3.2.1]octano, sua preparação e sua aplicação em terapêutica
BR9812752A (pt) Derivados de 8-azabiciclo [3.2.1] octano-3-metanamina enquanto ligandos dos receptores de dopamina d2 e d3 e de serotonina 5ht1a e 5ht2
BR0212839A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes e composição farmacêutica contendo os mesmos
BR0209102A (pt) Novos derivados 5-tio-beta.-d-xilopiranosìdeos, procedimento de preparação, composições farmacêuticas que os contém e sua utilização em terapêutica
BR0208245A (pt) Métodos para a preparação de compostos e compostos
YU16196A (sh) Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka
BR0009548A (pt) 3-bicicloaril-2-aminometil bicicloalcanos como inibidores da recaptação de serotonina
BR0214936A (pt) Benzotiofenos como moduladores do receptor de adenosina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.